Podcast: How the treatment landscape has changed for the better in relapsed-refractory CLL

Blood cancers

By Catherine Panwar

12 Apr 2018

Recent approvals of novel agents together with the ongoing development of combination regimes has opened up a realm of treatment options for people with chronic lymphocytic leukaemia. In this podcast we speak to Professor Paolo Ghia, Associate Professor in Internal Medicine at the Università Vita-Salute San Raffaele and local haematologist, Professor Stephen Opat, a Member of the Monash Health Translation Precinct about how the treatment landscape has changed for the better.

This podcast was sponsored by Janssen. The content is based on published studies and the opinions of independent experts. The views expressed are not necessarily those of Janssen. 


PLEASE REVIEW PRODUCT INFORMATION BEFORE PRESCRIBING (available from www.janssen.com.au/Imbruvica_PI).

Already a member?

Login to keep reading.

Email me a login link